Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis - PubMed (original) (raw)
Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis
Mikito Inokuchi et al. Cancer Chemother Pharmacol. 2004 May.
Abstract
Purpose: Expression of thymidylate synthase (TS) and the 5-fluorouracil (5-FU) metabolic enzymes, including dihydropyrimidine dehydrogenase (DPD), orotate phosphoribosyl transferase (OPRT), thymidine phosphorylase (TP), and uridine phosphorylase (UP), has been reported to be associated with the sensitivity to 5-FU-based chemotherapy in colorectal cancer. We evaluated the correlation of the expression of these genes between primary tumors and corresponding liver metastases.
Method: The mRNA levels of TS, DPD, OPRT, TP, and UP were measured by real-time quantitative RT-PCR in samples from 23 consecutive patients with both primary colorectal adenocarcinoma and liver metastasis.
Results: The DPD, OPRT, TP, and UP mRNA levels were significantly higher in liver metastases than in primary tumor (expression in relation to that of beta-actin mRNA: 0.42 vs 0.16, P=0.00053; 1.4 vs 0.92, P=0.016; 23 vs 11, P=0.00014; 0.36 vs 0.25, P=0.0026; respectively). However, the TS mRNA level did not differ significantly between liver metastases than primary tumor (0.20 vs 0.16, P=0.28). No correlation was observed for any gene between primary tumor and liver metastases. In both primary tumor and liver metastasis, the TS mRNA levels correlated significantly with the OPRT mRNA level (primary rS=0.83, P=0.00000081; liver metastasis rS=0.49, P=0.017), while the DPD mRNA level correlated significantly with the TP mRNA level rS=0.81, P=0.0000024; rS=0.63, P=0.0014; respectively).
Conclusions: The differential gene expression of 5-FU metabolic enzymes between primary colorectal cancer and corresponding liver metastases should be taken into consideration when estimating the sensitivity to 5-FU-based chemotherapy in colorectal cancer. The gene expression of TS and OPRT, which are involved in de novo pyrimidine synthesis, and that of DPD and TP, may be coregulated.
Similar articles
- Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
Okumura K, Shiomi H, Mekata E, Kaizuka M, Endo Y, Kurumi Y, Tani T. Okumura K, et al. Oncol Rep. 2006 Apr;15(4):875-82. Oncol Rep. 2006. PMID: 16525674 - Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy.
Kinoshita M, Kodera Y, Hibi K, Nakayama G, Inoue T, Ohashi N, Ito Y, Koike M, Fujiwara M, Nakao A. Kinoshita M, et al. Anticancer Res. 2007 Mar-Apr;27(2):851-6. Anticancer Res. 2007. PMID: 17465211 - [Expression of dihydropyrimidine dehydrogenase in primary colorectal cancer and liver metastasis--a relationship between mRNA levels in cancer cells and protein levels in cancerous tissue and effect of 5-fluorouracil].
Ishibashi K, Sobajima J, Ishiguro T, Ohsawa T, Okada N, Miyazaki T, Yokoyama M, Inokuma S, Ishida H. Ishibashi K, et al. Gan To Kagaku Ryoho. 2009 Nov;36(12):2232-5. Gan To Kagaku Ryoho. 2009. PMID: 20037380 Review. Japanese. - [Response marker to 5-FU after curative surgery in colorectal cancer].
Tsuji T. Tsuji T. Nihon Rinsho. 2003 Sep;61 Suppl 7:325-8. Nihon Rinsho. 2003. PMID: 14574904 Review. Japanese. No abstract available.
Cited by
- The tumour biology of synchronous and metachronous colorectal liver metastases: a systematic review.
Slesser AA, Georgiou P, Brown G, Mudan S, Goldin R, Tekkis P. Slesser AA, et al. Clin Exp Metastasis. 2013 Apr;30(4):457-70. doi: 10.1007/s10585-012-9551-8. Epub 2012 Nov 23. Clin Exp Metastasis. 2013. PMID: 23180209 Review. - Gene expression differences in primary colorectal tumors and matched liver metastases: chemotherapy related or tumoral heterogeneity?
López-Gómez M, Moreno-Rubio J, Suárez-García I, Cejas P, Madero R, Casado E, Jiménez AM, Sereno M, Gómez-Raposo C, Zambrana F, Merino M, Fernández-Luengas D, Feliu J. López-Gómez M, et al. Clin Transl Oncol. 2015 Apr;17(4):322-9. doi: 10.1007/s12094-014-1233-3. Epub 2014 Oct 10. Clin Transl Oncol. 2015. PMID: 25301403 - Thymidylate synthase and thymidine phosphorylase mRNA expression in primary lesions using laser capture microdissection is useful for prediction of the efficacy of FOLFOX treatment in colorectal cancer patients with liver metastasis.
Kumamoto K, Kuwabara K, Tajima Y, Amano K, Hatano S, Ohsawa T, Okada N, Ishibashi K, Haga N, Ishida H. Kumamoto K, et al. Oncol Lett. 2012 May;3(5):983-989. doi: 10.3892/ol.2012.598. Epub 2012 Feb 9. Oncol Lett. 2012. PMID: 22783377 Free PMC article. - Metastasis: a therapeutic target for cancer.
Steeg PS, Theodorescu D. Steeg PS, et al. Nat Clin Pract Oncol. 2008 Apr;5(4):206-19. doi: 10.1038/ncponc1066. Epub 2008 Feb 5. Nat Clin Pract Oncol. 2008. PMID: 18253104 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical